A potential drug for liver carcinoma
... proliferator-activated receptor γ (PPARγ), NF-κB, Bcl-2 and bax protein expression of HepG2 cells were analyzed by Western blotting. The... 24 h of treatment with 3.0, 10.0, 30.0 μmol/L ADFMChR, PPARγ and bax protein expression increased but Bcl-2 and NF-κB expression decreased ...Baxter International Shareholders Meeting
... DEERFIELD, Ill., April 27 /PRNewswire-FirstCall/ -- Baxter International (NYSE: bax ), will host its annual shareholders meeting on Tuesday, May 5, 2009, at 11:30 a.m. Eastern Time (10:30 a.m. Central Time) This call is being web...An adjuvant chemotherapeutic agent in gastric cancer therapy
... by fluorescent microscopy and flow cytometry. The expressions of Bcl-2 and bax were evaluated by immunostaining. After 24h of being treated with ga...ly suppress these changes, as well as regulate the expressions of Bcl-2 and bax in mesothelial cells. These findings demonstrated that gastric cancer cell ...Baxter International Fourth Quarter 2008 Financial Results Conference Call
... DEERFIELD, Ill., Jan. 6 /PRNewswire-FirstCall/ -- Baxter International (NYSE: bax ), will host a quarterly conference call to discuss its fourth quarter 2008 financial results on Thursday, January 22, 2009, at 8:30 a.m. Eastern Time...AmeriCares Launches India Operations
....americaresindia.org . About Baxter International: The Baxter International Foundation, the philanthropic arm of Baxter International Inc. (NYSE: bax ), helps organizations expand access to health care in the United States and around the world. The foundation, established in 1981, began to focus exc...Baxter International Second Quarter 2008 Financial Results Conference Call
... DEERFIELD, Ill., July 14 /PRNewswire-FirstCall/ -- Baxter International (NYSE: bax ), will host a quarterly conference call to discuss its second quarter 2008 financial results on Thursday, July 17, 2008, at 8:30 a.m. Eastern Time (7...Baxter Releases Ninth Annual Sustainability Report
...es Companywide Sustainability Goals to Drive Long-Term Progress DEERFIELD, Ill., June 19 /PRNewswire-FirstCall/ -- Baxter International Inc. (NYSE: bax ) today released its 2007 Sustainability Report -- Our Priorities. Our Progress., which highlights the company's 2007 social, economic and environment...St. Jude Researchers Find Key Step in Programmed Cell Death
...er that if active HtrA2 were present, the incorporation of a protein called bax into the mitochondrial outer membrane did not occur. This was significant since accumulation of bax in the outer mitochondrial membrane allows the release of proteins that set...Baxter Initiates Phase III Trial for the Treatment of Alzheimer's Disease
...id.com/hcp/index.html . About Baxter Baxter Healthcare Corporation is the principal U.S. operating subsidiary of Baxter International Inc. (NYSE: bax ). Baxter International Inc. develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, ...Baxter Presents Latest Clinical Trial Results of GAMMAGARD LIQUID Administered Subcutaneously
... in patients with Primary Immunodeficiency PHILADELPHIA, March 16 /PRNewswire-FirstCall/ -- Baxter International Inc. (NYSE: bax ) today announced the preliminary results of a Phase I/II clinical trial, in which subcutaneous infusion (under the skin) of GAMMAGARD LIQUID [Immune ...Baxter Announces Recombinant Factor IX Development Program For Hemophilia B
... DEERFIELD, Ill., Jan. 7 /PRNewswire-FirstCall/ -- Baxter International Inc. (NYSE: bax ) announced today that it has initiated pre-clinical programs to develop recombinant Factor IX proteins to treat hemophilia B. Baxter will develop bot...Honor Society of Nursing Recognizes Researcher of HIV Risk Prevention for Poor and Underserved
...n 2002 -- particularly for the disadvantaged and underserved -- in communities where Baxter employees live and work. Baxter International Inc. (NYSE: bax ), through its subsidiaries, assists health care professionals and their patients with the treatment of complex medical conditions, including hemophil...Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
... DEERFIELD, Ill., and LONDON, Aug. 16 /PRNewswire-FirstCall/ -- Baxter International Inc. (NYSE: bax ) announced today that Baxter's European subsidiary in the United Kingdom has entered into an advanced supply agreement with the Department of Health ...Vitamin D and calcium influence cell death in the colon, researchers find
...h calcium and vitamin D appeared to increase the levels of a protein called bax that controls programmed cell death in the colon. More bax might be pushing pre-cancerous cells into programmed cell death, says Emory...'Death protein' research secures funding for UCF scientists
...what triggers the death protein. The death protein bax appears to annihilate surrounding cells. If its se...drophobic groove within the molecular structure of bax could be the key to controlling the proteins letha...he form of a career development award to study how bax is activated to cause the death of immune cells. ...Ireland Cancer Center researchers advance stem cell gene therapy
...Matsuyama and colleagues presented a novel way of treating chemotherapy -induced thrombocytopenia (decrease in number of platelets in the blood) using bax Inhibiting Peptides to rescue the damaged cells. Dr. Keith McCrae and colleagues presented that 2 glycoprotein is a cofactor in the process th...Gene expression profile helps predict chemotherapy response in ovarian cancer patients
...onse to chemotherapy, as defined by the absence of disease at the time of second-look surgery. The CRP also confirmed the importance of genes such as bax in this process, which regulate the cell's response to chemotherapy agents such as paclitaxel. The authors then went on to compare the results of t...Baxter International First Quarter 2009 Financial Results Conference Call
... DEERFIELD, Ill., April 13 /PRNewswire-FirstCall/ -- Baxter International (NYSE: bax ), will host a quarterly conference call to discuss its first quarter 2009 financial results on Thursday, April 16, 2009, at 8:30 a.m. Eastern Time (7...Innocoll, Inc. Files 510 (k) Application for CollaRx Lidocaine Sponge
... Innocoll has licensed its US marketing rights to its lead product, CollaRx GENTAMICIN SURGICAL IMPLANT to a division of Baxter International (NYSE: bax ) The product is currently in phase 3 development in the US for the prevention of surgical site infections. It is approved for sale in 49 countries i...Baxter International Third Quarter 2008 Financial Results Conference Call
... DEERFIELD, Ill., Sept. 17 /PRNewswire-FirstCall/ -- Baxter International (NYSE: bax ), will host a quarterly conference call to discuss its third quarter 2008 financial results on Thursday, October 16, 2008, at 8:30 a.m. Eastern Time ...Baxter Named to Dow Jones Sustainability Index for Tenth Consecutive Year
... Company Named 2008 Medical Products Industry Leader DEERFIELD, Ill., Sept. 5 /PRNewswire-FirstCall/ -- Baxter International Inc. (NYSE: bax ) announced today that it has been named 2008 Medical Products Industry Leader of the Dow Jones Sustainability World Index (DJSI World) and the Dow Jo...Baxter Announces Licensing Agreement for Innocoll's Gentamicin Surgical Implant in the United States
...//www.innocollinc.com . About Baxter Baxter Healthcare Corporation is the principal U.S. operating subsidiary of Baxter International Inc. (NYSE: bax ). Baxter International Inc. develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, ...Baxter Declares Quarterly Dividend
... DEERFIELD, Ill., July 29 /PRNewswire-FirstCall/ -- The Board of Directors of Baxter International Inc. (NYSE: bax ) today declared a quarterly dividend of $0.2175 per share of Baxter common stock. This payment represents a continuation of the current rate, which...Baxter Raises Full-Year 2008 Outlook Following Strong Second-Quarter Financial Results
... Share, An Increase of 31 Percent DEERFIELD, Ill., July 17 /PRNewswire-FirstCall/ -- Baxter International Inc. (NYSE: bax ) today posted strong financial results for the second quarter of 2008 and raised its full-year financial outlook. For the second quarter, Baxter re...Baxter's Board of Directors Declares Quarterly Dividend
...rs and Ratify Auditor at Annual Meeting DEERFIELD, Ill., May 6 /PRNewswire-FirstCall/ -- The Board of Directors of Baxter International Inc. (NYSE: bax ) today announced a quarterly dividend and votes taken at the company's Annual Meeting of Shareholders held earlier today. Baxter's Board of Directo...